Barda, Noam
Dagan, Noa
Stemmer, Amos
Yuval, Janni
Bachmat, Eitan
Elnekave, Eldad https://orcid.org/0000-0002-3197-7338
Balicer, Ran
Article History
Received: 24 February 2021
Revised: 21 October 2021
Accepted: 21 December 2021
First Online: 16 March 2022
Declarations
:
: This study was approved by the CHS institutional review board.
: Patient consent was waived due to the retrospective nature of this study.
: Not applicable for this retrospective cohort analysis.
: Not applicable.
: EB and AS have nothing to disclose. NDag, NB, and RB report grants from Israel Innovation Authority during the conduct of the study. The parent company of Clalit Research Institute (ND, NB, JY, and RDB) owns a minority share in Zebra Medical Vision LTD, the company that developed the algorithm used. EE reported personal fees from Zebra Medical Vision Ltd., during the conduct of the study.